Pet Supplements Market Size and Share
Pet Supplements Market Analysis by Mordor Intelligence
The pet supplement market size, valued at USD 2.7 billion in 2025, is projected to reach USD 3.67 billion by 2030, registering a CAGR of 6.31%. Market expansion is attributed to the increasing emphasis on pet health and wellness, the development of premium functional formulations, and the growth of digital commerce platforms. Although specialty retailers maintain significant market presence, online subscription models are reshaping customer engagement and product replenishment strategies. The establishment of regulatory frameworks for cannabidiol (CBD) and clinical validation of targeted ingredients facilitates product portfolio expansion. Market participants emphasize acquisitions, scientific validation, and ingredient transparency, demonstrating that operational scale, consumer trust, and supply chain efficiency are critical determinants of market success.[1]U.S. Food & Drug Administration, “Animal Food & Feeds Updates,” fda.gov
Key Report Takeaways
- By product form, chewables and soft chews led with 39% of the pet supplement market share in 2024, while liquids and gels are on track to expand at an 8.5% CAGR through 2030.
- By supplement type, multivitamins held 28.7% share of the pet supplement market size in 2024; CBD and hemp derivatives are forecast for a 10.4% CAGR to 2030.
- By function, hip and joint health commanded 31.2% of the pet supplement market size in 2024; calming and anxiety relief is set to grow at a 9.7% CAGR.
- By pet type, dogs accounted for 45.7% revenue share in 2024, whereas cats represent the fastest-growing segment at a 7.1% CAGR.
- By distribution channel, specialty stores held 42.3% share of the pet supplement market in 2024; online channels record the highest projected CAGR at 12.6%.
- By geography, North America accounted for 48.4% of global revenue in 2024, while the Asia-Pacific region is projected to grow at a CAGR of 7.4% through 2030.
Global Pet Supplements Market Trends and Insights
Drivers Impact Analysis
Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Surge in CBD-infused supplement launches | +0.2% | North America, Europe | Medium term (2-4 years) |
Age-related osteoarthritis in senior dogs | +0.1% | Global | Long term (≥ 4 years) |
Subscription-based DTC e-commerce models expanding average order value | +0.2% | North America, Europe, Asia | Short term (≤ 2 years) |
Veterinary endorsement of probiotic formulas in companion-animal clinics | +0.1% | Global (developed markets) | Medium term (2-4 years) |
Demand for clean-label, plant-based formulations | +0.1% | North America, Europe, Asia | Medium term (2-4 years) |
Novel-food approval for algae-derived omega-3 ingredients | +0.1% | Europe, North America, Asia-Pacific | Medium term (2-4 years) |
Source: Mordor Intelligence
Surge in CBD-infused Supplement Launches
The United States CBD Product Safety and Standardization Act and European regulatory frameworks are simplifying market entry for CBD-infused pet products. In North America, 35% of pet supplement consumers use CBD products in 2025, mainly for anxiety management and mobility support, and 22% of veterinarians recommend CBD supplements to address behavioral issues and joint health. The expanding CBD and hemp derivatives market is driving the development of products that combine calming and anti-inflammatory benefits.
Age-related Osteoarthritis in Senior Dogs
The formulation of hip and joint supplements is evolving to incorporate UC-II collagen and omega-3 combinations. Clinical studies show these formulations provide better mobility outcomes than glucosamine supplements, leading veterinarians to recommend multi-modal treatment approaches. The market growth is supported by pet owners' increasing focus on preventive care, particularly for senior pets.
Subscription-Based DTC E-commerce Models Expanding Average Order Value
Subscription-based platforms demonstrate an increase in average order value compared to single-purchase transactions. Auto-delivery programs implemented by companies facilitate systematic replenishment, ensuring consistent revenue streams while generating valuable consumption data for formula optimization and targeted promotional activities. This business model proves particularly effective for daily supplement categories, including calming aids, probiotics, and multivitamins, resulting in a market share transition from traditional retail establishments.
Veterinary Endorsement of Probiotic Formulas in Companion-Animal Clinics
Veterinary recommendations influence pet owners' purchasing decisions. Veterinary clinics are incorporating probiotics into standard wellness protocols, driving an increase in product launches. Products with age-specific probiotic strains, higher colony-forming unit (CFU) counts, and clinical documentation command premium pricing and strengthen veterinarian confidence.
Restraints Impact Analysis
Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
---|---|---|---|
Stringent FDA and NASC compliance extending time-to-market | -0.1% | North America, Global | Short term (≤ 2 years) |
Volatile krill-oil supply chain raising input costs | -0.1% | Global | Short term (≤ 2 years) |
Price sensitivity among first-time supplement buyers | -0.1% | Global, emerging markets | Medium term (2-4 years) |
Consumer skepticism over efficacy of pet supplements | -0.1% | Global | Long term (≥ 4 years) |
Source: Mordor Intelligence
Stringent FDA and NASC Compliance Extending Time-to-Market
The FDA's termination of its memorandum of understanding with AAFCO requires companies to obtain ingredient approvals or Generally Recognized as Safe (GRAS) status. This increases research and development costs and extends product launch timelines. The National Animal Supplement Council (NASC) Quality Seal has emerged as the primary compliance standard, requiring enhanced clinical evidence and independent testing. These regulatory requirements impact the pace of innovation, especially in CBD and functional botanical products.
Volatile Krill-oil Supply Chain Raising Input Costs
Climate disruptions and harvest restrictions in Antarctic fisheries increased krill-oil prices by 15-20% since 2023. The elevated costs reduced operational margins, compelling manufacturers to explore algal and plant-based omega-3 alternatives, which present challenges in palatability and nutrient density. Organizations implement supply chain transparency measures, including vessel monitoring and quota compliance verification, to address consumer requirements regarding sustainable sourcing.
Segment Analysis
By Product Form: Chewable Retain Loyalty, Liquids Drive Innovation
Chewable and soft chews dominate the pet supplement market with a 39% share in 2024, primarily due to their flavor-masking capabilities and convenient dosing. Tablets and capsules maintain strong adoption in veterinary clinics, where precise dosage control and longer shelf life are essential. The liquid and gel segment shows the highest growth rate at 8.5% CAGR through 2030, particularly serving senior pets and those that have difficulty with solid supplements. Powders and dental chews complete the product range, offering multiple benefits such as joint support, calming effects, and skin health in single formulations. The market continues to evolve with new formats such as melt-in-mouth films for convenient administration.
The increasing focus on nutritional precision has driven innovations in dosage delivery, including liquid pump dispensers and cold-extrusion processes for chewables. Manufacturers address supply chain stability through dual-sourcing strategies for ingredients like gelatin and plant-based binders, while implementing sustainability certifications to meet retailer requirements. The emergence of combination supplement-snack products reflects consumer interest in functional treats, further strengthening the market position of chewable formats.
Note: Segment shares of all individual segments available upon report purchase
By Supplement Type: Multivitamins Anchor, CBD and Proteins Disrupt
Multivitamins hold 28.7% of the pet supplement market share in 2024, serving as a primary entry point for consumers seeking comprehensive wellness solutions. The market shows increased diversification through condition-specific supplements, particularly in immune health and senior care categories. CBD and hemp derivatives demonstrate strong growth with a 10.4% CAGR, supported by improving regulations and their effectiveness in both anxiety reduction and mobility enhancement. Proteins and peptides, particularly collagen formulations, gain prominence in joint health and dermatological applications, with notable adoption in Asian markets where fish-derived collagen meets regional preferences. The market maintains steady demand for omega-3s, probiotics, antioxidants, and botanical ingredients in specialized formulations.
Research validation emerges as a significant factor, with expanding clinical evidence supporting collagen-vitamin C combinations and lipid-encapsulated CBD formulations. Advanced proteomic analysis techniques improve peptide bioavailability, creating clear differentiation between premium products and standard multivitamin offerings in the market.
By Function: Joint Health Dominates, Calming and Anxiety Relief Accelerates
Hip and joint health supplements accounted for 31.2% of the pet supplement market size in 2024, driven by the increasing population of aging companion animals and pet owners' commitment to investing in long-term mobility solutions. Advanced formulations featuring UC-II collagen, green-lipped mussel, and boswellia serrata are replacing traditional glucosamine-only products, backed by clinical studies demonstrating improved pain reduction outcomes.[2]Frontiers in Veterinary Science, “Collagen Supplementation and Canine Mobility,” frontiersin.org
The calming and anxiety relief segment is growing at a 9.7% CAGR, responding to increased pet stress levels following post-pandemic schedule adjustments. Products containing L-theanine, chamomile, and CBD combinations are becoming essential components in pet evening routines and travel preparations. Digestive health, weight management, and skin and coat care segments maintain steady growth in the mid-single digits, with advances in probiotic diversity and fiber formulations. The market share for calming supplements is projected to exceed 17% by 2030, reflecting the increasing emphasis on behavioral health in veterinary care. While currently specialized, renal and cardiovascular support products show growth potential, supported by research on SGLT2 inhibitors and parsley extracts improving kidney function in cats.
By Pet Type: Dogs Drive Volume, Cats Gain Strategic Focus
Dogs represented 45.7% of revenue in 2024, attributed to increased supplement adoption, demonstrated return on investment in preventive care, and expanded breed-specific product offerings. Joint health, digestive support, and dental care supplements constitute the primary canine segment, while weight management products increase in correlation with obesity rates. The cat segment, demonstrating a 7.1% CAGR, receives substantial research and development investment as manufacturers address specific dietary requirements and health conditions, notably chronic kidney disease. Enhanced palatability through advanced flavor systems addresses historically low supplement acceptance in cats.
Birds, small mammals, and exotic pets comprise specialized market segments with growth potential through specialty retail education and online community engagement. The market for feline kidney health supplements is projected to triple by 2030, supported by clinical validation of amino acid formulations. Multi-pet households utilize universal supplements, such as probiotic powders, enabling retailers to optimize inventory management.

Note: Segment shares of all individual segments available upon report purchase
By Distribution Channel: Specialty Stores Hold, Online Channels Surge
Specialty stores account for 42.3% of pet supplement sales in 2024, attributed to their curated product selection and trained staff who provide supplement administration guidance. The strategic placement near premium pet foods and grooming services increases transaction values. The online channel demonstrates 12.6% CAGR growth, driven by subscription functionality, automated delivery discounts, and verified customer reviews that influence purchase decisions. The industry implements data analytics to generate supplement recommendations based on pet specifications and purchase patterns.
Veterinary clinics maintain their position as primary distributors of therapeutic supplements, including prescription renal formulations, while supermarkets facilitate the broad distribution of standard supplements such as multivitamins and dental products. Advanced logistics infrastructure and temperature-controlled distribution networks will facilitate the introduction of probiotic supplements and fresh formulations.
Geography Analysis
North America generated 48.4% of global revenue in 2024. The region's market leadership is attributed to high pet ownership rates, premium spending patterns, and a developed e-commerce infrastructure. Market expansion continues through increased veterinary adoption of functional ingredients and regulatory advancement regarding CBD supplements.[3] American Pet Products Association, “APPA National Pet Owners Survey,” americanpetproducts.org Canada and Mexico contribute additional growth through expanding middle-income populations and preventive pet care education initiatives.
Asia-Pacific exhibits the highest growth trajectory with a projected 7.4% CAGR through 2030. China, Japan, and India drive regional expansion through urbanization, middle-class expansion, and increasing pet humanization trends. International manufacturers adapt through market-specific flavors, appropriate package sizes, and comprehensive retail strategies across diverse regulatory frameworks.
Europe sustains market growth through Germany, the UK, and France, supported by stringent ingredient standards and a significant senior pet demographic. The market addresses consumer requirements for organic, plant-based, and scientifically validated formulations. South America, specifically Brazil, and the Middle East and Africa, particularly the UAE, demonstrate growth potential as Western consumption patterns expand through expatriate communities and digital market penetration.

Competitive Landscape
Major consumer packaged-goods companies, veterinary pharmaceutical firms, and private-equity investors are increasing market consolidation. Nestle Purina PetCare Company, Mars Incorporated (Mars Petcare), Colgate-Palmolive Company (Hill’s Pet Nutrition), General Mills Inc. (Blue Buffalo), and H&H Group – Zesty Paws combinedly occupied 41.2% market share in 2024. The companies are expanding through targeted acquisitions to address capability and ingredient gaps, as demonstrated by General Mills' USD 1.45 billion acquisition of Whitebridge Pet Brands in 2024. Clinical validation has become essential for retail placement, leading companies to publish peer-reviewed research on ingredient effectiveness.
Zesty Paws introduced an obesity-focused canine supplement in April 2025, expanding its weight-management product range. Virbac reported a 13.6% revenue increase in 2025, reflecting market demand for dental and dermatology products supported by veterinary endorsement. Patent protection, including Mars' US10709156B2 for probiotic tablets, enables companies to establish protected positions in condition-specific segments.
New market entrants focus on clean-label formulations, plant-based ingredients, and direct-to-consumer strategies that prioritize transparency and customer feedback. Start-up companies are implementing AI-based recommendation systems that connect supplements with data from pet wearables. Established companies respond through venture capital investments and development partnerships to enhance innovation. As vertical integration increases for essential ingredients like krill, collagen, and specialty botanicals, manufacturers with diverse supply sources will better manage price fluctuations in the pet supplement market.
Pet Supplements Industry Leaders
-
Nestle Purina PetCare Company
-
Mars Incorporated (Mars Petcare)
-
Colgate-Palmolive Company (Hill’s Pet Nutrition)
-
General Mills Inc. (Blue Buffalo)
-
H&H Group – Zesty Paws
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- March 2025: Zesty Paws introduced New Vet Strength, a canine obesity supplement that supports fat metabolism, digestion, and satiety in dogs. The product contains scientifically formulated ingredients to aid in weight management.
- February 2025: Fera Pets launched a dental support powder for pets that combines botanical ingredients with postbiotics. The product, Fera Pets Dental Support, addresses oral health concerns through internal supplementation. The formulation contains three primary ingredients: Oravestin, Bactase Pet, and a clinically tested postbiotic.
- December 2024: General Mills completed its USD 1.45 billion acquisition of Whitebridge Pet Brands’ North American portfolio.
- October 2024: Elanco received FDA approval for Credelio Quattro, a broad-spectrum parasiticide for dogs.
Global Pet Supplements Market Report Scope
Pet dietary supplements are feed supplements used with pet food to improve the nutritive balance or performance of the pet food consumed. These products are added to a pet's regular diet which contains ingredients intended to improve health.
The Pet Dietary Supplements Market is segmented by Specialty Type (Urinary Tract Diseases, Diabetes, Renal, Digestive Sensitivity, Oral Care, and Other Specialty Types), Pet Type (Dog, Cat, Bird, and Other Pet Types), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The report offers market size and forecasts in terms of value (USD) and Volume (Metric Tons) for the above-mentioned segments.
By Product Form | Tablets and Capsules | ||
Chewable and Soft Chews | |||
Powders | |||
Liquids and Gels | |||
Capsules | |||
Other Forms | |||
By Supplement Type | Multivitamins | ||
Probiotics and Prebiotics | |||
Omega-3 and Essential Fatty Acids | |||
Glucosamine and Chondroitin | |||
CBD and Hemp Derivatives | |||
Antioxidants | |||
Herbal and Botanical Extracts | |||
Other Supplement Type | |||
By Function | Urinary Tract Health | ||
Hip and Joint Health | |||
Diabetes Management | |||
Heart and Renal Health | |||
Skin and Coat Health | |||
Immune System Support | |||
Digestive Health | |||
Calming and Anxiety Relief | |||
Dental and Oral Care | |||
Metabolic/ Weight Management | |||
Senior/Cognitive Support | |||
Other Specialty Needs | |||
By Pet Type | Dogs | ||
Cats | |||
Birds | |||
Small Mammals | |||
Equine | |||
Aquatic | |||
Reptiles | |||
Other Pets | |||
By Distribution Channel | Convenience Stores | ||
Online Channel | |||
Specialty Stores | |||
Supermarkets/Hypermarkets | |||
Other Channels | |||
By Geography | North America | United States | |
Canada | |||
Mexico | |||
Rest of North America | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Russia | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
South Korea | |||
Australia | |||
Rest of Asia-Pacific | |||
South America | Brazil | ||
Argentina | |||
Chile | |||
Rest of South America | |||
Middle East | United Arab Emirates | ||
Saudi Arabia | |||
Israel | |||
Turkey | |||
Rest of Middle East | |||
Africa | South Africa | ||
Egypt | |||
Rest of Africa |
Tablets and Capsules |
Chewable and Soft Chews |
Powders |
Liquids and Gels |
Capsules |
Other Forms |
Multivitamins |
Probiotics and Prebiotics |
Omega-3 and Essential Fatty Acids |
Glucosamine and Chondroitin |
CBD and Hemp Derivatives |
Antioxidants |
Herbal and Botanical Extracts |
Other Supplement Type |
Urinary Tract Health |
Hip and Joint Health |
Diabetes Management |
Heart and Renal Health |
Skin and Coat Health |
Immune System Support |
Digestive Health |
Calming and Anxiety Relief |
Dental and Oral Care |
Metabolic/ Weight Management |
Senior/Cognitive Support |
Other Specialty Needs |
Dogs |
Cats |
Birds |
Small Mammals |
Equine |
Aquatic |
Reptiles |
Other Pets |
Convenience Stores |
Online Channel |
Specialty Stores |
Supermarkets/Hypermarkets |
Other Channels |
North America | United States |
Canada | |
Mexico | |
Rest of North America | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Russia | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
South Korea | |
Australia | |
Rest of Asia-Pacific | |
South America | Brazil |
Argentina | |
Chile | |
Rest of South America | |
Middle East | United Arab Emirates |
Saudi Arabia | |
Israel | |
Turkey | |
Rest of Middle East | |
Africa | South Africa |
Egypt | |
Rest of Africa |
Key Questions Answered in the Report
What is the current value of the pet supplement market?
The pet supplement market stands at USD 2.7 billion in 2025 and is forecast to reach USD 3.67 billion by 2030.
Which product form leads sales today?
Chewable and soft chews hold 39% of 2024 revenue thanks to palatability and simple dosing.
How fast are CBD-based pet supplements growing?
CBD and hemp derivatives are projected to advance at a 10.4% CAGR between 2025 and 2030.
Why are online channels gaining traction?
Subscription-driven direct-to-consumer platforms lift average order value by up to 23% and provide data for personalized targeting.
Which geographic region shows the strongest growth outlook?
Asia-Pacific is on course for a 7.4% CAGR as rising urban incomes and pet humanization accelerate supplement adoption.
What regulatory changes impact new product launches?
Stricter FDA ingredient approvals and wider NASC compliance requirements lengthen development timelines but also bolster consumer trust.
Page last updated on: July 7, 2025